ABOUT US
About IMCI Pharmaceuticals
Who We Are?
IMCI is a pharmaceutical company that develops innovative pharma-grade and formulated cannabis-based medications to treat chronic indications with a global reach.
IMCI has developed a precise and effective dose together with an easy-to-use administration, suitable for any patient population at any time and place via its iCann medicinal cannabis platform.
​
IMCI research and development is based on an Israeli leading academic research institution in collaboration with established Israeli pharmaceutical providers which together with its team members, possess a proven track record in developing innovative cannabis-based medications.
​
Our Vision
To become a leading pharmaceutical company, who will develop pharmaceutical and medicinal cannabis-based novel medicines to treat prevalent health conditions at an affordable price.
